CLOVOXAMINE AND DOXEPIN IN MAJOR DEPRESSIVE DISORDER - A DOUBLE-BLIND CONTROLLED TRIAL

被引：7
|
作者：
LODGE, GJ
FREEMAN, HL
机构：
[1] HOPE HOSP,SALFORD M6 8HD,LANCS,ENGLAND
[2] ROUNDWAY HOSP,DEVIZES SN10 5DS,WILTS,ENGLAND
来源：
BRITISH JOURNAL OF PSYCHIATRY | 1986年 / 148卷
关键词：
D O I：
10.1192/bjp.148.6.718
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：718 / 721
页数：4
相关论文
共 50 条
  • [21] Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial
    Shamabadi, Ahmad
    Karimi, Hanie
    Fallahzadeh, Mohammad Ali
    Vaseghi, Salar
    Bahri, Razman Arabzadeh
    Fallahpour, Bita
    Abdolghaffari, Amir Hossein
    Akhondzadeh, Shahin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2025, 40 (03) : 156 - 166
  • [22] Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
    Zuilhof, Zoe
    Norris, Sandhaya
    Blondeau, Claude
    Tessier, Pierre
    Blier, Pierre
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 3209 - 3218
  • [23] Omega 3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial
    Su, KP
    Chiu, CC
    Huang, SY
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 33S - 33S
  • [24] Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
    Amini, H
    Aghayan, S
    Jalili, SA
    Akhondzadeh, S
    Yahyazadeh, O
    Pakravan-Nejad, M
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (02) : 133 - 138
  • [25] Reboxetine:: a double-blind comparison with fluoxetine in major depressive disorder
    Massana, J
    Möller, HJ
    Burrows, GD
    Montenegro, RM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) : 73 - 80
  • [26] Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial
    Detke, MJ
    Lu, YL
    Goldstein, DJ
    Hayes, JR
    Demitrack, MA
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (04) : 308 - 315
  • [27] The Efficacy of Adjunctive N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial
    Berk, Michael
    Dean, Olivia M.
    Cotton, Sue M.
    Jeavons, Susan
    Tanious, Michelle
    Kohlmann, Kristy
    Hewitt, Karen
    Moss, Kirsteen
    Allwang, Christine
    Schapkaitz, Ian
    Robbins, Jenny
    Cobb, Heidi
    Ng, Felicity
    Dodd, Seetal
    Bush, Ashley I.
    Malhi, Gin S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (06) : 628 - U95
  • [28] Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
    Arabzadeh, Somaye
    Hakkikazazi, Elham
    Shahmansouri, Nazila
    Tafakhori, Abbas
    Ghajar, Alireza
    Jafarinia, Morteza
    Akhondzadeh, Shahin
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 235 : 236 - 241
  • [29] AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL
    Ghanizadeh, Ahmad
    Hedayati, Arvin
    DEPRESSION AND ANXIETY, 2013, 30 (11) : 1084 - 1088
  • [30] A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
    Arnold, LM
    Rosen, A
    Pritchett, YL
    D'Souza, DN
    Goldstein, DJ
    Iyengar, S
    Wernicke, JF
    PAIN, 2005, 119 (1-3) : 5 - 15
12345